- Report
- October 2025
- 186 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 184 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 181 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 189 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 199 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 192 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 196 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 185 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 198 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 183 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 187 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 196 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 181 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 181 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 181 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 192 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 195 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- August 2025
- 194 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 380 Pages
Global
From €5209EUR$5,850USD£4,535GBP
- Report
- October 2025
- 264 Pages
Global
From €5209EUR$5,850USD£4,535GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more